Zoha Ahmed is a Oklahoma City, Oklahoma based female rheumatologist who is specialized in Rheumatology. Active license number of Zoha Ahmed for Rheumatology is 45869 in Oklahoma. Zoha Ahmed treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Zoha Ahmed speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Female
Practice Address:
800 Stanton L Young Blvd # 6421, Oklahoma City, Oklahoma, 73104-5018
Phone:
405-271-6400
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467023721
NPI Enumeration Date:
08 Jul, 2021
NPI Last Update On:
27 Jun, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Zoha Ahmed are as mentioned below.
License Number
Specialization
State
Status
45869
Rheumatologist
Oklahoma
Primary
A196660
Internal Medicine
California
Secondary
A196660
Hospitalist
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
800 Stanton L Young Blvd # 6421, Oklahoma City, Oklahoma
Zip:
73104-5018
Phone Number:
--
Fax Number:
--
Patients can reach Zoha Ahmed at 800 Stanton L Young Blvd # 6421, Oklahoma City, Oklahoma or can call to book an appointment on 405-271-6400. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.